Anti-Aging Drug Boosts Brain Blood Flow in Adults With Higher Alzheimer's Risk, Pilot Study Finds
A four-week trial of low-dose rapamycin raised cerebral blood flow in middle-aged carriers of the APOE4 gene variant, with the biggest gains in women.
News Search
Search Results
A four-week trial of low-dose rapamycin raised cerebral blood flow in middle-aged carriers of the APOE4 gene variant, with the biggest gains in women.